145 related articles for article (PubMed ID: 36831131)
1. Mesenchymal Stem Cells Genetically Modified by Lentivirus-Express Soluble TRAIL and Interleukin-12 Inhibit Growth and Reduced Metastasis-Relate Changes in Lymphoma Mice Model.
Quiroz-Reyes AG; Gonzalez-Villarreal CA; Limon-Flores AY; Delgado-Gonzalez P; Martinez-Rodriguez HG; Said-Fernandez SL; Soto-Dominguez A; Rivas-Estilla AM; Islas JF; Molina-De la Garza JF; Garza-Treviño EN
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831131
[TBL] [Abstract][Full Text] [Related]
2. DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.
Yu R; Albarenque SM; Cool RH; Quax WJ; Mohr A; Zwacka RM
Cancer Biol Ther; 2014; 15(12):1658-66. PubMed ID: 25482930
[TBL] [Abstract][Full Text] [Related]
3. Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effects.
Yu R; Deedigan L; Albarenque SM; Mohr A; Zwacka RM
Cell Death Dis; 2013 Feb; 4(2):e503. PubMed ID: 23429289
[TBL] [Abstract][Full Text] [Related]
4. Targeting of XIAP combined with systemic mesenchymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcinoma cells.
Mohr A; Albarenque SM; Deedigan L; Yu R; Reidy M; Fulda S; Zwacka RM
Stem Cells; 2010 Nov; 28(11):2109-20. PubMed ID: 20882532
[TBL] [Abstract][Full Text] [Related]
5. Human Umbilical Cord MSC Delivered-Soluble TRAIL Inhibits the Proliferation and Promotes Apoptosis of B-ALL Cell In Vitro and In Vivo.
Chen F; Zhong X; Dai Q; Li K; Zhang W; Wang J; Zhao Y; Shen J; Xiao Z; Xing H; Li J
Pharmaceuticals (Basel); 2022 Nov; 15(11):. PubMed ID: 36422522
[TBL] [Abstract][Full Text] [Related]
6. [Interleukin-12 enhanced tumor necrosis factor related apoptosis-inducing ligand TRAIL-induced apoptosis in human hepatocellular carcinoma by inhibiting expression of survivin].
He SQ; Chen Y; Chen XP; Zhang WG; Wang HP; Zhang BX
Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):453-7. PubMed ID: 12895357
[TBL] [Abstract][Full Text] [Related]
7. A combined antitumor strategy of separately transduced mesenchymal stem cells with soluble TRAIL and IFNβ produces a synergistic activity in the reduction of lymphoma and mice survival enlargement.
Quiroz-Reyes AG; González-Villarreal CA; Martínez-Rodriguez H; Said-Fernández S; Salinas-Carmona MC; Limón-Flores AY; Soto-Domínguez A; Padilla-Rivas G; Montes De Oca-Luna R; Islas JF; Garza-Treviño EN
Mol Med Rep; 2022 Jun; 25(6):. PubMed ID: 35485288
[TBL] [Abstract][Full Text] [Related]
8. Human umbilical cord mesenchymal stem cells as vehicles of CD20-specific TRAIL fusion protein delivery: a double-target therapy against non-Hodgkin's lymphoma.
Yan C; Li S; Li Z; Peng H; Yuan X; Jiang L; Zhang Y; Fan D; Hu X; Yang M; Xiong D
Mol Pharm; 2013 Jan; 10(1):142-51. PubMed ID: 23121392
[TBL] [Abstract][Full Text] [Related]
9. Preclinical Biosafety Evaluation of Genetically Modified Human Adipose Tissue-Derived Mesenchymal Stem Cells for Clinical Applications to Brainstem Glioma.
Choi SA; Yun JW; Joo KM; Lee JY; Kwak PA; Lee YE; You JR; Kwon E; Kim WH; Wang KC; Phi JH; Kang BC; Kim SK
Stem Cells Dev; 2016 Jun; 25(12):897-908. PubMed ID: 27151205
[TBL] [Abstract][Full Text] [Related]
10. MSC.sTRAIL Has Better Efficacy than MSC.FL-TRAIL and in Combination with AKTi Blocks Pro-Metastatic Cytokine Production in Prostate Cancer Cells.
Mohr A; Chu T; Brooke GN; Zwacka RM
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 31010082
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibition of colorectal carcinoma by lentiviral TRAIL-transgenic human mesenchymal stem cells requires their substantial intratumoral presence.
Luetzkendorf J; Mueller LP; Mueller T; Caysa H; Nerger K; Schmoll HJ
J Cell Mol Med; 2010 Sep; 14(9):2292-304. PubMed ID: 19508388
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitor panobinostat potentiates the anti-cancer effects of mesenchymal stem cell-based sTRAIL gene therapy against malignant glioma.
Choi SA; Lee C; Kwak PA; Park CK; Wang KC; Phi JH; Lee JY; Chong S; Kim SK
Cancer Lett; 2019 Feb; 442():161-169. PubMed ID: 30367915
[TBL] [Abstract][Full Text] [Related]
13. Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model.
Kyriakou CA; Yong KL; Benjamin R; Pizzey A; Dogan A; Singh N; Davidoff AM; Nathwani AC
J Gene Med; 2006 Mar; 8(3):253-64. PubMed ID: 16288493
[TBL] [Abstract][Full Text] [Related]
14. Secreted TRAIL gene-modified adipose-derived stem cells exhibited potent tumor-suppressive effect in hepatocellular carcinoma cells.
Liu Z; Li S; Ma T; Zeng J; Zhou X; Li H; Tang M; Liu X; Li F; Jiang B; Zhao M; Chen Y
Immun Inflamm Dis; 2021 Mar; 9(1):144-156. PubMed ID: 33156578
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin Enhances the Apoptotic Effect of Mesenchymal Stem Cells, Delivering Soluble TRAIL in Chemoresistant Colorectal Cancer.
Quiroz-Reyes AG; Delgado-González P; Islas JF; Soto-Domínguez A; González-Villarreal CA; Padilla-Rivas GR; Garza-Treviño EN
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895919
[TBL] [Abstract][Full Text] [Related]
16. Suppression of orthotopically implanted hepatocarcinoma in mice by umbilical cord-derived mesenchymal stem cells with sTRAIL gene expression driven by AFP promoter.
Yan C; Yang M; Li Z; Li S; Hu X; Fan D; Zhang Y; Wang J; Xiong D
Biomaterials; 2014 Mar; 35(9):3035-43. PubMed ID: 24406219
[TBL] [Abstract][Full Text] [Related]
17. Engineered sTRAIL-armed MSCs overcome STING deficiency to enhance the therapeutic efficacy of radiotherapy for immune checkpoint blockade.
Huang KC; Chiang SF; Chang HY; Chen WT; Yang PC; Chen TW; Liang JA; Shiau AC; Ke TW; Clifford Chao KS
Cell Death Dis; 2022 Jul; 13(7):610. PubMed ID: 35835756
[TBL] [Abstract][Full Text] [Related]
18. Human umbilical cord mesenchymal stem cells delivering sTRAIL home to lung cancer mediated by MCP-1/CCR2 axis and exhibit antitumor effects.
Yan C; Song X; Yu W; Wei F; Li H; Lv M; Zhang X; Ren X
Tumour Biol; 2016 Jun; 37(6):8425-35. PubMed ID: 26733169
[TBL] [Abstract][Full Text] [Related]
19. Enhanced inhibition of tumor growth using TRAIL-overexpressing adipose-derived stem cells in combination with the chemotherapeutic agent CPT-11 in castration-resistant prostate cancer.
Kim JH; Oh E; Han YS; Lee SH; Song YS
Prostate Int; 2021 Mar; 9(1):31-41. PubMed ID: 33912512
[TBL] [Abstract][Full Text] [Related]
20. [Effects of Hippo signaling pathway on lung injury repair by mesenchymal stem cells in acute respiratory distress syndrome].
Li L; Dong L; Gao F; Hui J; Chen Y; Yan J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Mar; 31(3):281-287. PubMed ID: 30914086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
